A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
A phase 1/2 trial of SHR-1681 in advanced solid tumours, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., now recruiting.
Overview
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06737731 by Suzhou Suncadia Biopharmaceuticals Co., Ltd., with 300 participants planned, started 2025-01-21 and due to reach its primary completion in 2026-11. Interventions recorded: SHR-1681.
Similar pages
not linked directly; found by shared links- TrialA TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialHetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of SHR-4375 in Subjects With Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.